Page 1 of 2
Results 1 - 75 of 122
9916-0005_patients
Discussions with Patients to Optimize Asthma Control
9916-0004_treatment
Who Should be Targeted For Treatment With Biologic Therapy?
9916-0003_endotypes
Endotypes and Phenotypes in Asthma
9916-0002_moa3
Mechanisms of Action of Biologic Therapies for Severe Asthma
9916-0001_meds
Approved Medications for the Treatment of Severe Asthma
9907-0006_shared
Engage Your Patients in Shared Decision-Making
9907-0005_cardio
Is It IPF or Cardiovascular Disease?
9907-0004_ip
Interstitial Pneumonia with Autoimmune Features
9907-0003_pf-ild
How to Identify Progressive Fibrosing ILD
9907-0002_ctd
When Is It a Connective Tissue Disease?
9907-0001_guidelines
How to Use IPF Guidelines to Make a Diagnosis
9830-icon1
Updates in Atopic Dermatitis: Diagnosis and Management in Infants and Children
9830-icon2
Updates in Atopic Dermatitis: Diagnosis and Management in Adults
sma-icon
Are You Ready for Gene Replacement Therapy? Example from Spinal Muscular Atrophy
9916-kalluri
Advanced Care Planning and Palliative Care Models for Patients with IPF
9916-kalluri
Dyspnea Assessment in Patients with IPF
9916-scholand1
Which Patients with IPF Should be on Antifibrotics? The Value of Shared Decision Making
9916-brown5
Patient-Centered Outcomes for Patients with IPF: Activity Monitoring
9916-solomon
Connective Tissue Disease-Related ILD is Now in the Limelight
9916-brown5
Biomarkers in IPF and Other ILDs
9840-glassberg2
Evaluation and Diagnosis of IPF
9840-glassberg1
Initial Treatment Decisions of IPF
curesma19-icon
The Changing Landscape of SMA–Updates from Anaheim, CA
9840-lancaster
Optimizing Management of IPF
9837-coolidge
What if President Calvin Coolidge Was Your Asthma Patient?
9916-king
What are the Most Exciting Things Happening in Pulmonary Disease?
9837-roosevelt
How Would You Manage President Theodore Roosevelt’s Asthma Today?
9815-eugene
Eugene’s U(I)P-Hill Battle
9815-mary
Is Mary’s PAH Making You Dizzy?
9815-jane
Shedding Light on Jane’s ILD Diagnosis
9815-palliative
When Should You Consider Palliative Care in the Patient Journey?
9815-sandra
What is Your Treatment Recommendation for Sandra’s CTEPH?
9815-tracy
Tracy Has Chest Palpitations and Cough: What Does Her Imaging Tell Us?
9916-scholand
New Tools to Improve the Diagnosis of IPF vs Other ILDs
9916-brown
New Research on Therapies for Patients with Pulmonary Fibrosis
9916-richeldi
The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD
9916-cc-cme
2019 Summer Pulmonary Updates: The Experts Weigh In
philly-263x154
Philadelphia: The Next Level in Pulmonary Care
new haven_365x155
New Haven: The Next Level in Pulmonary Care
sma-journal-icon_263x0
Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease
med-doc-aatd
A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story
med-doc-ph
How Pulmonary Arterial Hypertension Has Changed Iain’s Life
9834-0002
SMA: Data, Insights and Practice
9829-0001
From Bench to Bedside: Gene Therapy Approaches for Rare Diseases
9834-00015
Expert Commentary on Recent Neurology Meetings
hopa-icon8
Biosimilars: Applying the Science to Hematology/Oncology Practice
9808-0005
Highlights From Recent Neurology Conferences in Mendoza and Chicago
9816-0001
The Latest from a Recent Pulmonary Conference in San Antonio
9816-0010
Updates in Inoperable CTEPH
9816-0009
The Importance of Early Integration of Palliative Care
9816-0006
Management of IPF Patients in 2018
9816-0005
Updates in the Diagnosis of ILD and the Role of Cryobiopsy
9816-00045
Overview of the Latest Clinical Trials in IPF
9816-0003
Evolution of Antifibrotic Therapy in IPF
9816-0002
Take Home Messages from the 2018 CHEST Annual Meeting
9816-0008
What We’re Learning from the IPF-PRO Registry
9816-0007
Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines
sma-whiteboard-icon copy
Transforming the Management of Spinal Muscular Atrophy
aims icon
Advances in Multiple Sclerosis (AIMS) Primer
9804-0001
Transformative Treatment for SMA
9808-sma-grs
Gene Replacement Therapy Education for the Multidisciplinary Team
sma-aav vector-icon copy2
Gene Replacement Therapy for SMA Management
9808-0004
What’s New in Spinal Muscular Atrophy? Reporting from Dallas
atopic-derm4
Atopic Dermatitis: Putting it Together (Dermatology)
atopic-derm3
Atopic Dermatitis: Putting it Together (Primary Care)
atopic-derm2 copy
Atopic Dermatitis: Recent and Emerging Therapies
atopic-derm1
An Introduction to Atopic Dermatitis
9808-0003
SMA Updates from Los Angeles
pah icon
PAH Today: Mastering Current, Tailored Treatment
asthma-severe icon
Achieving Better Control of Severe Asthma
asthma-uncontrol icon
A Personalized Approach to Managing Uncontrolled Asthma
9808-0002
Updates in SMA and Gene Therapy from Arlington, VA
biosims-archmed icon23
Top Questions about Biosimilars in Dermatology
biosims-archmed icon1
Top Questions about Biosimilars in Gastroenterology
biosims-archmed icon2
Top Questions about Biosimilars in Rheumatology
Page 1 of 2

Search